Advanced search
Publication Cover
Renal Failure Volume 38, 2016 - Issue 1
Submit an article Journal homepage
1,034
Views
9
CrossRef citations to date
0
Altmetric
Clinical Study

Kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy

Kuo-Hua LeeSchool of Medicine, National Yang-Ming University, Taipei, Taiwan, ;Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
,
Yung-Tai ChenSchool of Medicine, National Yang-Ming University, Taipei, Taiwan, ;Department of Medicine, Taipei City Hospital Heping Fuyou Branch, Taipei, Taiwan,
,
Hsiao-Jen ChungSchool of Medicine, National Yang-Ming University, Taipei, Taiwan, ;Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan,
,
Jia-Sin LiuDivision of Preventive Medicine and Health Services Research, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan,
,
Chih-Cheng HsuDivision of Preventive Medicine and Health Services Research, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan,
&
Der-Cherng TarngSchool of Medicine, National Yang-Ming University, Taipei, Taiwan, ;Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ;Department and Institute of Physiology, National Yang-Ming University, Taipei, Taiwan, and ;Genome, Infection and Immunity Research Center, National Yang-Ming University, Taipei, TaiwanCorrespondence[email protected]
Pages 77-83 | Received 01 Jun 2015, Accepted 28 Sep 2015, Published online: 29 Oct 2015

References

  • Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300
  • Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades. J Urol. 2000;164:1523–1525
  • Ljungberg B, Cowan NC, Hanbury DC, et al. EAU guidelines on renal cell carcinoma: The 2010 update. Eur Urol. 2010;58:398–406
  • Roupret M, Babjuk M, Comperat E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63:1059–1071
  • Li W, Cheng Y, Cheng Y, et al. Clinical efficacy of radical nephrectomy versus nephron-sparing surgery on localized renal cell carcinoma. Eur J Med Res. 2014;19:58
  • Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study. Lancet Oncol. 2006;7:735–740
  • Kim CS, Bae EH, Ma SK, et al. Impact of partial nephrectomy on kidney function in patients with renal cell carcinoma. BMC Nephrol. 2014;15:181
  • Mariusdottir E, Jonsson E, Marteinsson VT, et al. Kidney function following partial or radical nephrectomy for renal cell carcinoma: A population-based study. Scand J Urol. 2013;47:476–482
  • Meyer JP, Delves GH, Sullivan ME, Keoghane SR. The effect of nephroureterectomy on glomerular filtration rate. BJU Int. 2006;98:845–848
  • Kaag MG, O'Malley RL, O'Malley P, et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol. 2010;58:581–587
  • Kaag M, Trost L, Thompson RH, et al. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int. 2014;114:674–679
  • Chung JS, Son NH, Byun SS, et al. Trends in renal function after radical nephrectomy: A multicentre analysis. BJU Int. 2014;113:408–415
  • Lane BR, Campbell SC, Demirjian S, Fergany AF. Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease. J Urol. 2013;189:1649–1655
  • Moch H, Artibani W, Delahunt B, et al. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol. 2009;56:636–643
  • Roscigno M, Cha EK, Rink M, et al. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis. BJU Int. 2012;110:674–681
  • Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–735
  • Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509
  • Vincenti F, Amend WJ Jr, Kaysen G, et al. Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects. Transplantation. 1983;36:626–629
  • Williams SL, Oler J, Jorkasky DK. Long-term renal function in kidney donors: A comparison of donors and their siblings. Ann Intern Med. 1986;105:1–8
  • Hew MN, Opondo D, Cordeiro ER, et al. The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same. BJU Int. 2014;113:E49–E55
  • Peces R, Alvarez-Navascues R. Unilateral renal cell carcinoma with coexistent renal disease: A rare cause of end-stage renal disease. Nephrol Dial Transplant. 2001;16:291–294
  • Wang SM, Lai MN, Chen PC, et al. Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: A nationwide cohort study in Taiwan during 1997–2008. Biomed Res Int. 2014;2014:149750
  • Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer. 1999;85:1342–1344
  • Lai MN, Wang SM, Chen PC, et al. Population-based case–control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst. 2010;102:179–186
  • Lai MN, Lai JN, Chen PC, et al. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: A population-based case–control study. Am J Kidney Dis. 2010;55:507–518
  • Nortier JL, Schmeiser HH, Muniz Martinez MC, et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant. 2003;18:426–428
  • Simhan J, Smaldone MC, Egleston BL, et al. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int. 2014;114:216–220

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.